SymbioTec (Germany) Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $43.7K

  • Investors
  • 1

SymbioTec (Germany) General Information

Description

Developer of medicines for cancer and infectious diseases. The company develops and markets pharmaceutical products for therapy and diagnostics of life-threatening diseases. It produces and sales medicines focused on treatment of acute lymphocytic and myeloid leukaemia.

Contact Information

Website
www.symbiotec.biz
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Science Park Saar 1
  • 66123 Saarbrucken
  • Germany
+49 0681
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Acquirer
Xenetic Bioscience
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Science Park Saar 1
  • 66123 Saarbrucken
  • Germany
+49 0681

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SymbioTec (Germany) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 01-Nov-2022 $43.7K Completed Generating Revenue
4. Merger/Acquisition 17-Jan-2012 Completed Generating Revenue
3. Later Stage VC 15-Mar-2011 Completed Generating Revenue
2. Later Stage VC 18-Aug-2009 $1.4M $1.4M Completed Generating Revenue
1. Early Stage VC 01-Jan-2001 Completed Startup
To view SymbioTec (Germany)’s complete valuation and funding history, request access »

SymbioTec (Germany) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SymbioTec (Germany) Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Artgen biotech Corporation Minority
Gradus Venture Venture Capital Minority
To view SymbioTec (Germany)’s complete investors history, request access »

Ready to get started?

Request a free trial

SymbioTec (Germany) FAQs

  • When was SymbioTec (Germany) founded?

    SymbioTec (Germany) was founded in 1999.

  • Where is SymbioTec (Germany) headquartered?

    SymbioTec (Germany) is headquartered in Saarbrucken, Germany.

  • What is the size of SymbioTec (Germany)?

    SymbioTec (Germany) has 4 total employees.

  • What industry is SymbioTec (Germany) in?

    SymbioTec (Germany)’s primary industry is Drug Discovery.

  • Is SymbioTec (Germany) a private or public company?

    SymbioTec (Germany) is a Private company.

  • What is SymbioTec (Germany)’s current revenue?

    The current revenue for SymbioTec (Germany) is .

  • How much funding has SymbioTec (Germany) raised over time?

    SymbioTec (Germany) has raised $1.4M.

  • Who are SymbioTec (Germany)’s investors?

    Artgen biotech and Gradus Venture have invested in SymbioTec (Germany).

  • When was SymbioTec (Germany) acquired?

    SymbioTec (Germany) was acquired on 01-Nov-2022.

  • Who acquired SymbioTec (Germany)?

    SymbioTec (Germany) was acquired by Xenetic Bioscience.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »